Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

INTRODUCTION: Loss of HBeAg and development of anti-HBe (seroconversion) is seen as a milestone and endpoint in the treatment of HBeAg-positive patients with chronic hepatitis B (CHB). Among patients treated with nucleos (t)ide analogs (NA), recurrent viremia is common after discontinuation of thera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dig Dis Sci
Hauptverfasser: Fong, Tse-Ling, Tien, Andy, Jo, Kahee J., Chu, Danny, Cheung, Eddie, Mena, Edward A., Phan, Quang-Quoc, Yu, Andy S., Mohammed, Wafa, Velasco, Andrew, LeDuc, Vinh-Huy, Nguyen, Nickolas, Han, Steven-Bui, Chang, Mimi, Bae, Ho S., Cho, Yong-Won, Tong, Myron J., Cooper, Stewart L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4803449/
https://ncbi.nlm.nih.gov/pubmed/26138653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-015-3775-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge